BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32533247)

  • 21. Decision regret after prostate biopsy for prostate cancer diagnosis: a Korean multicenter cohort study.
    Kim H; Bang W; Shim M; Oh CY; Cho SY; Chung MS; Cho DS; Kim SI; Lee SH; Koo KC; Lee KS; Cho JS
    BMC Public Health; 2024 Jun; 24(1):1725. PubMed ID: 38943112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
    Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
    J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome study.
    Wilding S; Downing A; Selby P; Cross W; Wright P; Watson EK; Wagland R; Kind P; Donnelly DW; Hounsome L; Mottram R; Allen M; Kearney T; Butcher H; Gavin A; Glaser A
    Psychooncology; 2020 May; 29(5):886-893. PubMed ID: 32065691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data.
    Albisinni S; Mélot C; Aoun F; Limani K; Peltier A; Rischmann P; van Velthoven R
    J Endourol; 2018 Sep; 32(9):797-804. PubMed ID: 29790383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
    Lunger L; Meissner VH; Kopp BCG; Dinkel A; Schiele S; Ankerst DP; Gschwend JE; Herkommer K
    BMC Urol; 2023 Aug; 23(1):139. PubMed ID: 37612591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
    Peters M; Kanthabalan A; Shah TT; McCartan N; Moore CM; Arya M; van der Voort van Zyp JR; Moerland MA; Hindley RG; Emberton M; Ahmed HU
    Urol Oncol; 2018 Jan; 36(1):13.e1-13.e10. PubMed ID: 28927782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial.
    Cuypers M; Lamers RED; Kil PJM; van de Poll-Franse LV; de Vries M
    Patient Educ Couns; 2019 Mar; 102(3):424-428. PubMed ID: 30314830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
    Shaverdian N; Verruttipong D; Wang PC; Kishan AU; Demanes DJ; McCloskey S; Kupelian P; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):516-525. PubMed ID: 28126301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.
    Wallis CJD; Zhao Z; Huang LC; Penson DF; Koyama T; Kaplan SH; Greenfield S; Luckenbaugh AN; Klaassen Z; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Hoffman KE; Barocas DA
    JAMA Oncol; 2022 Jan; 8(1):50-59. PubMed ID: 34792527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
    Nguyen PL; Chen MH; Hoffman KE; Chen RC; Hu JC; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV
    BJU Int; 2012 Jul; 110(2):201-5. PubMed ID: 22085233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.
    Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J
    Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes.
    Shoji S; Nakano M; Fujikawa H; Endo K; Hashimoto A; Tomonaga T; Terachi T; Uchida T
    Int J Urol; 2015 Nov; 22(11):1043-9. PubMed ID: 26251127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment decision regret and related factors following radical prostatectomy.
    Lin YH
    Cancer Nurs; 2011; 34(5):417-22. PubMed ID: 21242766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes.
    Palermo G; Totaro A; Sacco E; Foschi N; Gulino G; Racioppi M; Bassi P; Pinto F
    Minerva Urol Nefrol; 2017 Feb; 69(1):93-100. PubMed ID: 28009150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused Ultrasound.
    Mortezavi A; Krauter J; Gu A; Sonderer J; Bruhin J; Reeve KA; Held L; Donati OF; Rupp NJ; Moch H; Sulser T; Eberli D
    J Urol; 2019 Oct; 202(4):717-724. PubMed ID: 31042109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time pressure predicts decisional regret in men with localized prostate cancer: data from a longitudinal multicenter study.
    Hilger C; Schostak M; Otto I; Kendel F
    World J Urol; 2021 Oct; 39(10):3755-3761. PubMed ID: 34021406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unmet expectations in prostate cancer patients and their association with decision regret.
    Wollersheim BM; van Stam MA; Bosch RJLH; Pos FJ; Tillier CN; van der Poel HG; Aaronson NK
    J Cancer Surviv; 2020 Oct; 14(5):731-738. PubMed ID: 32385837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.